Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wiliam Nseir"'
Autor:
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit, Mahmud Mahamid
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2019 (2019)
Background and Aims. We aimed to assess whether chronic statins used (> 6 months) were protective of the development of esophagitis in patients with gastroesophageal reflux disease. In the presence of esophagitis, complications such as strictures, Ba
Externí odkaz:
https://doaj.org/article/1f04b2e828a84e71bafaf077b5a227aa
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:1110-1115
The progression of nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis (NASH) is believed to be the driver for future development of fibrosis and cirrhosis. Nevertheless, there remains a lack of noninvasive methods for the diagno
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12:1743-1749
Background Abdominal aortic aneurysm (AAA) and fatty liver disease are both associated with the metabolic syndrome (MS); the aim of this study was to investigate whether patients with AAA are also at a higher risk for fatty liver disease. Methods A c
Autor:
Abdulla Watad, Mohamed Jabaren, Wisam Sbeit, Hana Amara, Mahmud Mahamid, Wiliam Nseir, Tawfik Khoury, Amir Mari
Publikováno v:
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology and Hepatology, Vol 2019 (2019)
Canadian Journal of Gastroenterology and Hepatology, Vol 2019 (2019)
Background and Aims. We aimed to assess whether chronic statins used (> 6 months) were protective of the development of esophagitis in patients with gastroesophageal reflux disease. In the presence of esophagitis, complications such as strictures, Ba
Autor:
Baker Mahamid, Mahmud Mahamid, Wiliam Nseir, Eran Goldin, Wisam Sbeit, Amir Mari, Kamal Sub-Laban, Joel Schifter, Tawfik Khoury, Adi Nubania
Publikováno v:
European Journal of Gastroenterology & Hepatology
AIM: Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was declared a pandemic by WHO in 2020. Obesity and other components of the metabolic syndrome may aggravate the severity of COVID-19. Nonalcoholic fatty liver disease (N
Autor:
Hana Amara, Jabaren Mohamed, Mahmud Mahamid, Wiliam Nseir, Amir Mari, Tawfik Khoury, Hisham Sholy, Rafea Shalabi, Mahmoud Siadi
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Mahmud Mahamid,1–3,* Tawfik Khoury,1,* Hana Amara,1 Mahmoud Siadi,1,3 Jabaren Mohamed,4 Amir Mari,1 Rafea Shalabi,5 Hisham Sholy,6 Wiliam Nseir3 1Gastroenterology and Liver Diseases Unit, EEMS, The Nazareth Hospital, Nazareth, Israel; 2Faculty of M
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Background Abdominal aortic aneurysm (AAA) and fatty liver disease are both associated with the metabolic syndrome (MS); the aim of this study was to investigate whether patients with AAA are also at a higher risk for fatty liver disease. Methods A c